NCT07005869Not yet recruiting
Brachial Plexus Tumors; Pathological Types and Surgical Approaches: Multi Center Experience
Source: ClinicalTrials.gov · Last updated 5 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Brachial plexus tumors, are rare, present significant challenges due to their intricate anatomical location and potential impact on upper limb function. These tumors arise from nerve sheath cells, including either benign schwannomas and neurofibromas, or as malignant peripheral nerve sheath tumors (MPNSTs), which require early diagnosis and intervention to improve patient outcomes (1). Surgical resection remains the primary treatment modality, aiming to alleviate symptoms and prevent further neurological compromise.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 21 May 2025
- Start date
- 30 May 2025
- Primary completion date
- 1 May 2027
- Lead sponsor
- Assiut University
- Diseases
- Childhood cancers
- NCT number
- NCT07005869
What you commit to
- Study type: Interventional
- Planned participants: 15
- From 30 May 2025 to the primary completion date, 1 May 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- .Patients with recurrent tumors previously treated.
- .Patients who are unfit for surgery.
Other
- . Patients with non-tumorous brachial plexus pathologies (e.g., trauma, inflammation).
- .Patients with incomplete medical records or lost follow-up data.
Who the study is looking for
- .Patients diagnosed with brachial plexus tumors confirmed through imaging
- .Age of Patients: Any age .
- .patients who are fit for surgery .
Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.